Latest updates
- In the press OBN Awards 2025
- In the press Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
- In the press Exonate appoints Dr Rafiq Hasan as Non-Executive Director
- Insights Biotech Showcase, San Francisco 2024
- Insights Exonate at Biotrinity 2022
- Insights Exonate announces involvement in exciting STEM outreach project.
- Insights Exonate at RANZCO – 8-12th November 2019, International Convention Centre Sydney (ICC)